MTHFD2 and breast cancer: Moreover, suppression of MTHFD2 in MCF-7 breast cancer cells caused prominent metabolic remodeling, such as greater vulnerability to exogenous folate depletion, enhanced glycolytic flux, and increased glutamine consumption (44).